SCHEMBL6507306

SCHEMBL6507306

O=C(c1ccccc1O)C1CC1c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.53
ALDH1A1 P00352 3/20 0.51
DEGS1 O15121 2/20 0.49
FFAR1 O14842 1/20 0.49
SLC9A1 P19634 1/20 0.49
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KDM4E B2RXH2 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
HMGB1 P09429 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
NAPRT Q6XQN6 1/20 0.47
CA14 Q9ULX7 1/20 0.47
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31451062 0.78 HDAC4 (0.59) HDAC4ALDH1A1DEGS1FFAR1SLC9A1
SCHEMBL13975670 0.78 HDAC4 (0.59) HDAC4ALDH1A1DEGS1FFAR1SLC9A1
SCHEMBL29172119 0.77 HDAC4 (0.58) HDAC4ALDH1A1DEGS1FFAR1SLC9A1
SCHEMBL29172117 0.77 HDAC4 (0.58) HDAC4ALDH1A1DEGS1FFAR1SLC9A1
SCHEMBL2034678 0.75 FFAR1 (0.70) HDAC4ALDH1A1DEGS1FFAR1SLC9A1
SCHEMBL5217474 0.75 FFAR1 (0.70) HDAC4ALDH1A1DEGS1FFAR1SLC9A1
SCHEMBL8295172 0.75 FFAR1 (0.70) HDAC4ALDH1A1DEGS1FFAR1SLC9A1
SCHEMBL323823 0.75 FFAR1 (0.70) HDAC4ALDH1A1DEGS1FFAR1SLC9A1
SCHEMBL4126470 0.75 FFAR1 (0.70) HDAC4ALDH1A1DEGS1FFAR1SLC9A1
SCHEMBL323824 0.75 FFAR1 (0.70) HDAC4ALDH1A1DEGS1FFAR1SLC9A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005037810-A2 CYCLOPROPYL METHANONE DERIVATIVES, THE PREPARATION AND THE THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2005-04-28 WO claimed
WO-2005018541-A2 COX-2 INHIBITOR AND SEROTONIN MODULATOR FOR TREATING CNS DAMAGE PHARMACIA CORPORATION (US) 2005-03-03 WO disclosed